Vitamin A in Stargardt disease—an evidence-based update

References

• OMIM Entry - # 248200 - STARGARDT DISEASE 1; STGD1 [Internet]. [cited 2017 Nov 29]. Available from: https://www.omim.org/entry/248200?search=STGD1&highlight=stgd1
   Google Scholar
• Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy. Genet N. 1997;15(3):236. doi:10.1038/ng0397-236. Cited in PubMed; PMID:9054934.
   PubMed Web of Science ®Google Scholar
• Cornish KS, Ho J, Downes S, Scott NW, Bainbridge J, Lois N. The epidemiology of stargardt disease in the United Kingdom. Ophthalmol Retina. 2017;1(6):508–13. doi:10.1016/j.oret.2017.03.001.
   Google Scholar
• Prokofyeva E., Wilke R., Lotz G., Troeger E., Strasser T., Zrenner E. An epidemiological approach for the estimation of disease onset in Central Europe in central and peripheral monogenic retinal dystrophies .Graefes Arch Ophthalmol CE. 2009;247(7):885–94. doi:10.1007/s00417-009-1059-9. Cited in PubMed; PMID:19277693.
   PubMed Web of Science ®Google Scholar
• Cremers FP, van de Pol DJ, van Driel M., den Hollander AI, vanHaren FJ, Knoers NV, Tijmes N., Bergen AA, Rohrschneider K., Blankennagel A. et al. autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt’s disease gene ABCR. Hum Mol Genet. 1998;7(3):355–62. doi: 10.1093/hmg/7.3.355. Cited in PubMed; PMID:9466990.
   PubMed Web of Science ®Google Scholar
• Bertelsen M., Zernant J., Larsen M., Duno M., Allikmets R., Rosenberg T. Generalized choriocapillaris dystrophy, a distinct phenotype in the spectrum of ABCA4-associated retinopathies. Invest Ophthalmol Vis Sci. 2014;55(4):2766–76. doi:10.1167/iovs.13-13391. Cited in PubMed; PMID:24713488.
   PubMed Web of Science ®Google Scholar
• Allikmets R. Simple and complex ABCR: genetic predisposition to retinal disease. Am J Hum Genet. 2000;67(4):793–99. doi:10.1086/303100. Cited in PubMed; PMID:10970771.
   PubMed Web of Science ®Google Scholar
• Adler L, Boyer NP, Chen C, Ablonczy Z, Crouch RK, Koutalos Y. Chapter e-thirty-one - the 11-cis retinal origins of lipofuscin in the retina. Hejtmancik JF, Nickerson JM. editors. Progress in molecular biology and translational science [internet]. Academic Press; 2015 cited 2018 Jan 3. 1–12. Molecular Biology of Eye Disease; vol. 134. Available from. http://www.sciencedirect.com/science/article/pii/S1877117315001544.
   Google Scholar
• Quazi F, Molday RS. ATP-binding cassette transporter ABCA4 and chemical isomerization protect photoreceptor cells from the toxic accumulation of excess 11-cis-retinal. Proc Natl AcadSci. 2014;111(13):5024–29. doi:10.1073/pnas.1400780111. Cited in PubMed; PMID:24707049.
   PubMed Web of Science ®Google Scholar
• Facts About Stargardt Disease | National Eye Institute [Internet]. [cited 2017 Nov 23]. Available from: https://nei.nih.gov/health/stargardt/star_facts
   Google Scholar
• Wiseman EM, Dadon SB-E, Reifen R. The vicious cycle of vitamin a deficiency: A review. Crit Rev Food Sci Nutr.2017;57(17):3703–14. doi:10.1080/10408398.2016.1160362. Cited in PubMed; PMID:27128154.
   PubMed Web of Science ®Google Scholar
• Radu RA, Han Y, Bui TV, Nusinowitz S, Bok D, Lichter J, Widder K, Travis GH, Mata NL. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci. 2005;46(12):4393–401. doi:10.1167/iovs.05-0820. Cited in PubMed: 16303925.
   PubMed Web of Science ®Google Scholar
• Radu RA, Yuan Q, Hu J, Peng JH, Lloyd M, Nusinowitz S, Bok D, Travis GH. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation. Invest Ophthalmol Vis Sci. 2008;49(9):3821–29. doi:10.1167/iovs.07-1470. Cited in PubMed; PMID:18515570.
   PubMed Web of Science ®Google Scholar
• Kratz K, Newsome D, May J. Changes in ERG amplitude following laser induced damage to the primate retina. Curr Eye Res 1990. 9(5):435–44. doi:10.3109/02713689008999609. Cited in PubMed; PMID:2383998.
   PubMed Web of Science ®Google Scholar
• Tsybovsky Y, Molday RS, Palczewski K. TheATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease. Adv Exp Med Biol 2010.703.105–25. doi:10.1007/978-1-4419-5635-4_8. Cited in PubMed; PMID:20711710.
   PubMed Web of Science ®Google Scholar
• Sofi F., A S, Franco F, Murro V, Biagini D, Miele A, Abbruzzese G, Mucciolo DP, Virgili G, Menchini U et al. Dietary profile of patients with Stargardt’s disease and retinitis pigmentosa: is there a role for a nutritional approach? BMC Ophthalmol. 2016;16(1):13. doi: 10.1186/s12886-016-0187-3. Cited in PubMed; PMID:26801981.
   PubMedGoogle Scholar
• Kong X, Strauss RW, Cideciyan AV, Michaelides M, Sahel J-A, Munoz B, Ahmed M, Ervin AM, West SK, Cheetham JK et al. Visual acuity change over 12 months in the prospective progression of atrophy secondary to Stargardt disease (ProgStar) study: ProgStar report number 6. Ophthalmology. 2017;124(11):1640–51. doi: 10.1016/j.ophtha.2017.04.026. Cited in PubMed; PMID:28549516.
   PubMed Web of Science ®Google Scholar
• Bravo-Gil N, Méndez-Vidal C, Romero-Pérez L, Pozo MG, R J la Dopazo, Borrego S, Antinolo G.Improving the management of inherited retinal dystrophies by targeted sequencing of a population-specific gene panel. Sci Rep. 2016;(6):23910. doi:10.1038/srep23910. Cited in PubMed; PMID:27032803.
   PubMedGoogle Scholar
• Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease - Full Text View - ClinicalTrials.gov [Internet]. [cited 2017 Dec 15]. Available from: https://clinicaltrials.gov/ct2/show/NCT02402660
   Google Scholar
• Saad L, Washington I.Can vitamin A be improved to prevent blindness due to age-related macular degeneration, Stargardt disease and other retinal dystrophies? Adv Exp Med Biol. 2016;(854):355–61. doi:10.1007/978-3-319-17121-0_47. Cited in PubMed; PMID:26427432.
   PubMedGoogle Scholar
• Issa PC, Barnard AR, Herrmann P., Washington I., MacLaren RE. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. Proc Natl Acad Sci U S A. 2015;112(27):8415–20. doi:10.1073/pnas.1506960112. Cited in PubMed; PMID:26106163.
   PubMed Web of Science ®Google Scholar
• Ma L, Kaufman Y, Zhang J.Washington I. C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease. J Biol Chem 2011. 286(10):7966–74. doi:10.1074/jbc.M110.178657. Cited in PubMed; PMID:21156790.
   PubMed Web of Science ®Google Scholar
• Issa PC, Barnard AR, Singh MS, Carter E, Jiang Z, Radu RA, Schraermeyer U, MacLaren RE. Fundus autofluorescence in the Abca4−/− mouse model of Stargardt disease—correlation with accumulation of A2E, retinal function, and histology. Invest Ophthalmol Vis Sci. 2013;54(8):5602–12. doi:10.1167/iovs.13-11688. Cited in PubMed; PMID:23761084.
   PubMed Web of Science ®Google Scholar
• Washington I., Saad L.The rate of vitamin A dimerization in lipofuscinogenesis, fundus autofluorescence, retinal senescence and degeneration. Adv Exp Med Biol. 2016;854.347–53. doi:10.1007/978-3-319-17121-0_46. Cited in PubMed; PMID:26427431.
   PubMed Web of Science ®Google Scholar
• About the Study - ProgStar [Internet]. [cited 2018 Feb 28]. Available from: http://progstar.org/progstar-home/about-the-study/
   Google Scholar
• Phase 1 Safety Study of ALK-001 in Healthy Volunteers - Full Text View - ClinicalTrials.gov [Internet]. [cited 2018 Jan 26]. Available from: https://clinicaltrials.gov/ct2/show/NCT02230228
   Google Scholar